Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Precision radiation boost aims to control prostate cancer with fewer side effects

NCT ID NCT01596816

First seen Mar 16, 2026 · Last updated May 18, 2026 · Updated 14 times

Summary

This study tested a new radiation plan for men with intermediate-risk prostate cancer. 76 participants received standard radiation to the prostate and nearby glands, plus an extra-high dose of radiation (stereotactic boost) directly to the tumor. The goal was to improve cancer control while keeping side effects to the bladder and rectum low. The study measured changes in urinary and rectal function over time.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Centre Alexis Vautrin

    Vandœuvre-lès-Nancy, 54500, France

  • Centre Georges François Leclerc

    Dijon, 21079, France

  • Centre Hospitalier Lyon Sud

    Pierre-Bénite, 69310, France

  • Centre Léon Bérard

    Lyon, 69373, France

  • Centre Oscar LAMBRET

    Lille, 59020, France

  • Centre Paul Papin

    Angers, 49933, France

  • Val d'Aurelle-Paul Lamarque

    Montpellier, 34298, France

Conditions

Explore the condition pages connected to this study.